IL13 and colitis: Whereas, rCsCP ameliorated the acute colitis might through activating innate immunity, downregulating the expression of pro-inflammatory factors (IL-12, IL-23r and IL-7), and promoting the production of anti-inflammatory factors (IL-10, IL-4 and IL-13).